Gallbladder Treatment Market Research Report - Global Forecast till 2023

Gallbladder Treatment Market Research Report - Global Forecast till 2023

ID: MRFR/HC/2643-CRR | September, 2017 | Region: Global | 94 pages | Cooked Research Reports

Gall bladder treatment market information, by disease indications (gallstones, cholecystitis and biliary colic, cholelithiasis and choledocholithiasis, gallbladder polyps, gall bladder cancer), by diagnosis (ultrasound, blood tests, computerized tomography (CT), cholangiography and hepatobiliary scintigraphy), by treatment (surgery, drugs), by end users (hospitals & gynecology clinics, academic & research centers) - Global forecast till 2023


Market Scenario


The gall bladder is a small pear-shaped located underneath the liver. Its main function is to store the bile produced by liver and pass it along through a duct that empties into the small intestine. Gall bladder diseases affect a large number of people in the world. Gallbladder and biliary related diseases occurred in about 104 million people (1.6%) in 2013 and they resulted in 106,000 deaths. The major driving factors for the growth of the market are increasing geriatric population, increasing prevalence rate of various gallbladder diseases, and introduction & adoption of advanced diagnostic treatment options. Moreover, increasing awareness of the diseases, rising healthcare expenditure, and rising demand from emerging markets of Asia have fuelled the market growth. However, pain and complications during surgery and asymptomatic nature of gallstones may slow the growth of the market.


The market for gall bladder treatment is growing at a healthy rate. The market is expected to grow at the CAGR of 6.5% during the forecast period and is estimated to reach USD 27121.5 million by 2023.


Figure- Global gall bladder treatment market, by diseases indication (2016) (%)
gall bladder treatment market, by diseases indication


Source: American Gastroenterological Association, NCBI, Gastroenterological Society of Australia, British Society of Gastroenterology Directorate of Industries, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


Key Findings



  • Ultrasound segment accounts for the largest market share in the global gall bladder treatment market while Computerized tomography (CT) segment is projected to grow at a CAGR of 7.10% during the forecast period from 2017 – 2023.

  • Surgery segment accounts for the largest market share in the global gall bladder treatment market by Treatment, this segment is expected to reach USD 1 in 2023

  • North Americas market is expected to reach USD 10,584.8 by 2023


Intended Audience



  • Gall Bladder Products Manufacturers

  • Gall Bladder Products Providers

  • Medical Research Laboratories

  • Research and Development (R&D) Companies

  • Market Research and Consulting Service Providers

  • Potential Investors


Research Methodology
Research Methodology gallbladder treatment market


 Source: American Gastroenterological Association, NCBI, Gastroenterological Society of Australia, British Society of Gastroenterology Directorate of Industries, Expert Interview Market Research Future Analysis, Annual report, White paper, Company Presentation


 


Segments                                                                                                                                            


Global gall bladder treatment market has been segmented on the basis of disease indications, diagnosis, treatment and end users. On the basis of disease indications the market is segmented as gallstones, cholecystitis & biliary colic, cholelithiasis & choledocholithiasis, gallbladder polyps, gall bladder cancer. On the basis of diagnosis the market is categorized as ultrasound, blood tests, computerized tomography (CT), cholangiography and hepatobiliary scintigraphy and others. On the basis of treatment the market is segmented into surgery, and drugs and on the basis of end users the market is divided into hospitals & gynecology clinics, academic & research centers and others.


Regional analysis                    


Considering the global scenario of the market, North America dominates the global gall bladder treatment market owing to the presence of huge population suffering from gall bladder diseases. US holds the largest market share in North America gall bladder treatment market. In developed countries, 10–15% of adults have gallstones. Europe has the second largest market for the gall bladder treatment which is followed by Asia Pacific. Presence of well-developed healthcare sector and high healthcare expenditure, the gall bladder treatment market in Europe is growing at a CAGR of 6.8%. Asia Pacific is also witnessing a rapid growth in this market which is mainly due to rapidly increasing awareness of treatments, presence of huge population, rising healthcare expenditure and government support for research & development. Asia Pacific gall bladder treatment market is expected to grow at a CAGR of 7.0% during the forecasted period. The Middle East & Africa is expected to have limited growth.


Key players for global gall bladder treatment market                                           


Some of the major players in this market are: Boston Scientific Corporation, Intuitive Surgical, C. R. Bard, Inc., Dornier MedTech, Koninklijke Philips N.V., B. Braun Melsungen AG, Sanofi and others

The report for Global Gall Bladder Treatment Market of Market Research Future comprises of extensive primary research along with the detailed analysis of qualitative as well as quantitative aspects by various industry experts, key opinion leaders to gain deeper insight to the market and industry performance. The report gives a clear picture of the current market scenario which includes historical and projected market size in terms of value and volume, technological advancement, macro economical and governing factors in the market. The report provides details information and strategies of the top key players in the industry. The report also gives a broad study of the different market segments and regions

License

Single User Enterprise User (Buy Premium Reports Chapterwise)
Currency

TABLE OF CONTENTS

2.1 Scope of Study 19

2.2 Research Objective 19

2.3 Assumptions & Limitations 20

2.3.1 Assumptions 20

2.3.2 Limitations 20

2.4 Market Structure 20

3.1 Introduction 21

3.2 Primary Research 22

3.3 Secondary research 22

3.4 Market Size Estimation 23

4.1 Drivers 25

4.1.1 Development of minimal invasive surgical procedures 25

4.1.2 Rise in risk factors 25

4.1.3 Advancements in surgical procedures 26

4.2 Restraints 26

4.2.1 Pain and complications during surgery 26

4.2.2 Asymptomatic nature of gallstones 26

4.2.3 Excellent effectiveness and comparative cost effectiveness of surgery 27

4.3 Opportunities 27

4.3.1 Research and development 27

4.4 Challenges 27

4.4.1 High cost of cholecystectomy and robotic laparoscopy surgery 27

4.4.2 Stringent regulations and regulatory uncertainties in the US 27

4.4.3 Low public healthcare expenditure in developing regions 28

5.1 Porter’s Five Forces Analysis 29

5.1.1 Threat from a New Entrant 30

5.1.2 Bargaining Power of Buyer 30

5.1.3 Bargaining Power of Supplier 30

5.1.4 Threat from substitute 31

5.1.5 Intensity of Competitive Rivalry 31

5.2 Supply Chain Analysis 32

5.2.1 Raw Material 32

5.2.2 Supplier 33

5.2.3 Manufacturer 33

5.2.4 Distributer 34

5.2.5 Customer-Retailer 34

5.2.6 Consumer 34

5.3 Technology Trends & Assessment 35

5.3.1 Extracorporeal shockwave lithotripsy (ESWL) 35

5.3.2 Laser lithotripsy 35

5.3.3 Miniaturization of surgical instruments and development of alternative forms of surgeries 35

5.3.4 Robotic surgeries 36

5.3.5 Advancements in biliary stents 36

6.1 Introduction 37

6.2 Gall stone 38

6.3 Cholecystitis and biliary colic 39

6.4 Cholelithiasis and Choledocholithiasis 40

6.5 Gallbladder polyps 41

6.6 Gall bladder cancer 41

7.1 Ultrasound 44

7.2 Blood tests 44

7.3 Computerized tomography (CT) 46

7.4 Cholangiography and hepatobiliary scintigraphy 47

9.1 Hospitals and Gynecology Clinics 53

9.2 Academic and Research Centers 53

10.1 North America 55

10.1.1 US 58

10.1.2 Canada 61

10.2 Europe 64

10.2.1 Germany 68

10.2.2 France 71

10.2.3 UK 74

10.2.4 ITALY 77

10.2.5 SPAIN 80

10.2.6 REST OF EUROPE 83

10.3 Asia Pacific 87

10.3.1 JAPAN 90

10.3.2 CHINA 93

10.3.3 INDIA 96

10.3.4 AUSTRALIA 99

10.3.5 REPUBLIC OF KOREA 102

10.3.6 REST OF ASIA PACIFIC 106

10.4 Middle East & Africa 109

10.5 Middle East 112

10.6 Africa 115

11.1 Mergers Acquisitions 119

11.2 Approvals and Product Launches 121

11.3 Clearance 122

11.4 Others 123

12.1 Boston Scientific Corporation 126

12.1.1 Company Overview 126

12.1.2 Product Overview 126

12.1.3 Financial Overview 127

12.1.4 Key Development 128

12.1.5 SWOT 129

12.2 Intuitive Surgical 130

12.2.1 Company Overview 130

12.2.2 Product Overview 130

12.2.3 Financial Overview 130

12.2.4 Key Development 131

12.2.5 SWOT 132

12.3 C. R. Bard, Inc. 133

12.3.1 Company Overview 133

12.3.2 Product Overview 133

12.3.3 Financial Overview 134

12.3.4 Key Development 135

12.3.5 SWOT 136

12.4 Dornier MedTech 137

12.4.1 Company Overview 137

12.4.2 Product Overview 137

12.4.3 Financial Overview 137

12.4.4 Key Development 137

12.4.5 SWOT 138

12.5 Koninklijke Philips N.V. 139

12.5.1 Company Overview 139

12.5.2 Financial Overview 140

12.5.3 Key Developments 141

12.5.4 SWOT Analysis 143

12.6 B. Braun Melsungen AG 144

12.6.1 Overview 144

12.6.2 Product Overview 144

12.6.3 Financial Overview 145

12.6.4 Key Development 146

12.6.5 SWOT Analysis 147

12.7 Sanofi 148

12.7.1 Company Overview 148

12.7.2 Product Overview 148

12.7.3 Sanofi: Financial Overview 149

12.7.4 Key Development 149

12.7.5 SWOT 150



TABLE 1 GLOBAL GALL BLADDER TREATMENT MARKET BY DISEASE INDICATION US$ MILLION 2014-2023 37

TABLE 2 GLOBAL GALL BLADDER TREATMENT MARKET FOR GALL STONE US$ MILLION 2014-2023 38

TABLE 3 GLOBAL GALL BLADDER TREATMENT MARKET FOR CHOLECYSTITIS AND BILIARY COLIC US$ MILLION 2014-2023 39

TABLE 4 GLOBAL GALL BLADDER TREATMENT MARKET FOR CHOLELITHIASIS AND CHOLEDOCHOLITHIASIS US$ MILLION 2014-2023 40

TABLE 5 GLOBAL GALL BLADDER TREATMENT MARKET FOR GALLBLADDER POLYPS US$ MILLION 2014-2023 41

TABLE 6 GLOBAL GALL BLADDER TREATMENT MARKET FOR GALL BLADDER CANCER US$ MILLION 2014-2023 42

TABLE 7 GLOBAL GALL BLADDER TREATMENT MARKET BY DIAGNOSIS US$ MILLION 2014-2023 43

TABLE 8 GLOBAL GALL BLADDER TREATMENT MARKET FOR ULTRASOUND US$ MILLION 2014-2023 44

TABLE 9 GLOBAL GALL BLADDER TREATMENT MARKET FOR BLOOD TESTS US$ MILLION 2014-2023 45

TABLE 10 GLOBAL GALL BLADDER TREATMENT MARKET FOR COMPUTERIZED TOMOGRAPHY (CT) US$ MILLION 2014-2023 46

TABLE 11 GLOBAL GALL BLADDER TREATMENT MARKET FOR CHOLANGIOGRAPHY AND HEPATOBILIARY SCINTIGRAPHY US$ MILLION 2014-2023 47

TABLE 12 GLOBAL GALL BLADDER TREATMENT MARKET BY TREATMENT US$ MILLION 2014-2023 48

TABLE 13 GLOBAL GALL BLADDER TREATMENT MARKET FOR SURGERY US$ MILLION 2014-2023 50

TABLE 14 GLOBAL GALL BLADDER TREATMENT MARKET FOR DRUGS US$ MILLION 2014-2023 51

TABLE 15 GLOBAL GALL BLADDER TREATMENT MARKET BY END USERS US$ MILLION 2014-2023 52

TABLE 16 GLOBAL GALL BLADDER TREATMENT MARKET FOR HOSPITALS AND GYNECOLOGY CLINICS US$ MILLION 2014-2023 53

TABLE 17 GLOBAL GALL BLADDER TREATMENT MARKET FOR ACADEMIC AND RESEARCH CENTERS US$ MILLION 2014-2023 53

TABLE 18 GLOBAL GALL BLADDER MARKET BY REGION US$ MILLION 2014-2023 54

TABLE 19 NORTH AMERICA GALL BLADDER MARKET BY REGION US$ MILLION 2014-2023 55

TABLE 20 NORTH AMERICA GALL BLADDER TREATMENT MARKET BY DISEASE INDICATION US$ MILLION 2014-2023 56

TABLE 21 NORTH AMERICAGALL BLADDER TREATMENT MARKET BY DIAGNOSIS US$ MILLION 2014-2023 56

TABLE 22 NORTH AMERICA GALL BLADDER TREATMENT MARKET BY TREATMENT US$ MILLION 2014-2023 57

TABLE 23 NORTH AMERICAGALL BLADDER TREATMENT MARKET BY END USERS US$ MILLION 2014-2023 58

TABLE 24 US GALL BLADDER TREATMENT MARKET BY DISEASE INDICATION US$ MILLION 2014-2023 58

TABLE 25 US GALL BLADDER TREATMENT MARKET BY DIAGNOSIS US$ MILLION 2014-2023 59

TABLE 26 US GALL BLADDER TREATMENT MARKET BY TREATMENT US$ MILLION 2014-2023 60

TABLE 27 US GALL BLADDER TREATMENT MARKET BY END USERS US$ MILLION 2014-2023 61

TABLE 28 CANADA GALL BLADDER TREATMENT MARKET BY DISEASE INDICATION US$ MILLION 2014-2023 61

TABLE 29 CANADA GALL BLADDER TREATMENT MARKET BY DIAGNOSIS US$ MILLION 2014-2023 62

TABLE 30 CANADA GALL BLADDER TREATMENT MARKET BY TREATMENT US$ MILLION 2014-2023 63

TABLE 31 CANADA GALL BLADDER TREATMENT MARKET BY END USERS US$ MILLION 2014-2023 64

TABLE 32 EUROPE GALL BLADDER MARKET BY REGION US$ MILLION 2014-2023 64

TABLE 33 EUROPE GALL BLADDER TREATMENT MARKET BY DISEASE INDICATION US$ MILLION 2014-2023 65

TABLE 34 EUROPE GALL BLADDER TREATMENT MARKET BY DIAGNOSIS US$ MILLION 2014-2023 66

TABLE 35 EUROPE GALL BLADDER TREATMENT MARKET BY TREATMENT US$ MILLION 2014-2023 67

TABLE 36 EUROPE GALL BLADDER TREATMENT MARKET BY END USERS US$ MILLION 2014-2023 68

TABLE 37 GERMANY GALL BLADDER TREATMENT MARKET BY DISEASE INDICATION US$ MILLION 2014-2023 68

TABLE 38 GERMANY GALL BLADDER TREATMENT MARKET BY DIAGNOSIS US$ MILLION 2014-2023 69

TABLE 39 GERMANY GALL BLADDER TREATMENT MARKET BY TREATMENT US$ MILLION 2014-2023 70

TABLE 40 GERMANY GALL BLADDER TREATMENT MARKET BY END USERS US$ MILLION 2014-2023 71

TABLE 41 FRANCE GALL BLADDER TREATMENT MARKET BY DISEASE INDICATION US$ MILLION 2014-2023 71

TABLE 42 FRANCE GALL BLADDER TREATMENT MARKET BY DIAGNOSIS US$ MILLION 2014-2023 72

TABLE 43 FRANCE GALL BLADDER TREATMENT MARKET BY TREATMENT US$ MILLION 2014-2023 73

TABLE 44 FRANCE GALL BLADDER TREATMENT MARKET BY END USERS US$ MILLION 2014-2023 74

TABLE 45 UK GALL BLADDER TREATMENT MARKET BY DISEASE INDICATION US$ MILLION 2014-2023 74

TABLE 46 UK GALL BLADDER TREATMENT MARKET BY DIAGNOSIS US$ MILLION 2014-2023 75

TABLE 47 UK GALL BLADDER TREATMENT MARKET BY TREATMENT US$ MILLION 2014-2023 76

TABLE 48 UK GALL BLADDER TREATMENT MARKET BY END USERS US$ MILLION 2014-2023 77

TABLE 49 ITALY GALL BLADDER TREATMENT MARKET BY DISEASE INDICATION US$ MILLION 2014-2023 77

TABLE 50 ITALY GALL BLADDER TREATMENT MARKET BY DIAGNOSIS US$ MILLION 2014-2023 78

TABLE 51 ITALY GALL BLADDER TREATMENT MARKET BY TREATMENT US$ MILLION 2014-2023 79

TABLE 52 ITALY GALL BLADDER TREATMENT MARKET BY END USERS US$ MILLION 2014-2023 80

TABLE 53 SPAIN GALL BLADDER TREATMENT MARKET BY DISEASE INDICATION US$ MILLION 2014-2023 80

TABLE 54 SPAIN GALL BLADDER TREATMENT MARKET BY DIAGNOSIS US$ MILLION 2014-2023 81

TABLE 55 SPAIN GALL BLADDER TREATMENT MARKET BY TREATMENT US$ MILLION 2014-2023 82

TABLE 56 SPAIN GALL BLADDER TREATMENT MARKET BY END USERS US$ MILLION 2014-2023 83

TABLE 57 REST OF EUROPE GALL BLADDER TREATMENT MARKET BY DISEASE INDICATION US$ MILLION 2014-2023 83

TABLE 58 REST OF EUROPE GALL BLADDER TREATMENT MARKET BY DIAGNOSIS US$ MILLION 2014-2023 84

TABLE 59 REST OF EUROPE GALL BLADDER TREATMENT MARKET BY TREATMENT US$ MILLION 2014-2023 85

TABLE 60 REST OF EUROPE GALL BLADDER TREATMENT MARKET BY END USERS US$ MILLION 2014-2023 86

TABLE 61 ASIA PACIFIC GALL BLADDER MARKET BY REGION US$ MILLION 2014-2023 87

TABLE 62 ASIA PACIFIC GALL BLADDER TREATMENT MARKET BY DISEASE INDICATION US$ MILLION 2014-2023 88

TABLE 63 ASIA PACIFIC GALL BLADDER TREATMENT MARKET BY DIAGNOSIS US$ MILLION 2014-2023 88

TABLE 64 ASIA PACIFIC GALL BLADDER TREATMENT MARKET BY TREATMENT US$ MILLION 2014-2023 89

TABLE 65 ASIA PACIFIC GALL BLADDER TREATMENT MARKET BY END USERS US$ MILLION 2014-2023 90

TABLE 66 JAPAN GALL BLADDER TREATMENT MARKET BY DISEASE INDICATION US$ MILLION 2014-2023 90

TABLE 67 JAPAN GALL BLADDER TREATMENT MARKET BY DIAGNOSIS US$ MILLION 2014-2023 91

TABLE 68 JAPAN GALL BLADDER TREATMENT MARKET BY TREATMENT US$ MILLION 2014-2023 92

TABLE 69 JAPAN GALL BLADDER TREATMENT MARKET BY END USERS US$ MILLION 2014-2023 93

TABLE 70 CHINA GALL BLADDER TREATMENT MARKET BY DISEASE INDICATION US$ MILLION 2014-2023 93

TABLE 71 CHINA GALL BLADDER TREATMENT MARKET BY DIAGNOSIS US$ MILLION 2014-2023 94

TABLE 72 CHINA GALL BLADDER TREATMENT MARKET BY TREATMENT US$ MILLION 2014-2023 95

TABLE 73 CHINA GALL BLADDER TREATMENT MARKET BY END USERS US$ MILLION 2014-2023 96

TABLE 74 INDIA GALL BLADDER TREATMENT MARKET BY DISEASE INDICATION US$ MILLION 2014-2023 96

TABLE 75 INDIA GALL BLADDER TREATMENT MARKET BY DIAGNOSIS US$ MILLION 2014-2023 97

TABLE 76 INDIA GALL BLADDER TREATMENT MARKET BY TREATMENT US$ MILLION 2014-2023 98

TABLE 77 INDIA GALL BLADDER TREATMENT MARKET BY END USERS US$ MILLION 2014-2023 99

TABLE 78 AUSTRALIA GALL BLADDER TREATMENT MARKET BY DISEASE INDICATION US$ MILLION 2014-2023 99

TABLE 79 AUSTRALIA GALL BLADDER TREATMENT MARKET BY DIAGNOSIS US$ MILLION 2014-2023 100

TABLE 80 AUSTRALIA GALL BLADDER TREATMENT MARKET BY TREATMENT US$ MILLION 2014-2023 101

TABLE 81 AUSTRALIA GALL BLADDER TREATMENT MARKET BY END USERS US$ MILLION 2014-2023 102

TABLE 82 REPUBLIC OF KOREA GALL BLADDER TREATMENT MARKET BY DISEASE INDICATION US$ MILLION 2014-2023 102

TABLE 83 REPUBLIC OF KOREA GALL BLADDER TREATMENT MARKET BY DIAGNOSIS US$ MILLION 2014-2023 103

TABLE 84 REPUBLIC OF KOREA GALL BLADDER TREATMENT MARKET BY TREATMENT US$ MILLION 2014-2023 104

TABLE 85 REPUBLIC OF KOREA GALL BLADDER TREATMENT MARKET BY END USERS US$ MILLION 2014-2023 105

TABLE 86 REST OF ASIA PACIFIC GALL BLADDER TREATMENT MARKET BY DISEASE INDICATION US$ MILLION 2014-2023 106

TABLE 87 REST OF ASIA PACIFIC GALL BLADDER TREATMENT MARKET BY DIAGNOSIS US$ MILLION 2014-2023 106

TABLE 88 REST OF ASIA PACIFIC GALL BLADDER TREATMENT MARKET BY TREATMENT US$ MILLION 2014-2023 107

TABLE 89 REST OF ASIA PACIFIC GALL BLADDER TREATMENT MARKET BY END USERS US$ MILLION 2014-2023 108

TABLE 90 MIDDLE EAST & AFRICA GALL BLADDER MARKET BY REGION US$ MILLION 2014-2023 109

TABLE 91 MIDDLE EAST & AFRICA GALL BLADDER TREATMENT MARKET BY DISEASE INDICATION US$ MILLION 2014-2023 110

TABLE 92 MIDDLE EAST & AFRICA GALL BLADDER TREATMENT MARKET BY DIAGNOSIS US$ MILLION 2014-2023 110

TABLE 93 MIDDLE EAST & AFRICA GALL BLADDER TREATMENT MARKET BY TREATMENT US$ MILLION 2014-2023 111

TABLE 94 MIDDLE EAST & AFRICA GALL BLADDER TREATMENT MARKET BY END USERS US$ MILLION 2014-2023 112

TABLE 95 MIDDLE EAST GALL BLADDER TREATMENT MARKET BY DISEASE INDICATION US$ MILLION 2014-2023 112

TABLE 96 MIDDLE EAST GALL BLADDER TREATMENT MARKET BY DIAGNOSIS US$ MILLION 2014-2023 113

TABLE 97 MIDDLE EAST GALL BLADDER TREATMENT MARKET BY TREATMENT US$ MILLION 2014-2023 114

TABLE 98 MIDDLE EAST GALL BLADDER TREATMENT MARKET BY END USERS US$ MILLION 2014-2023 115

TABLE 99 AFRICA GALL BLADDER TREATMENT MARKET BY DISEASE INDICATION US$ MILLION 2014-2023 115

TABLE 100 AFRICA GALL BLADDER TREATMENT MARKET BY DIAGNOSIS US$ MILLION 2014-2023 116

TABLE 101 AFRICA GALL BLADDER TREATMENT MARKET BY TREATMENT US$ MILLION 2014-2023 117

TABLE 102 AFRICA GALL BLADDER TREATMENT MARKET BY END USERS US$ MILLION 2014-2023 118

TABLE 103 BOSTON SCIENTIFIC CORPORATION: PRODUCT OVERVIEW 126

TABLE 104 BOSTON SCIENTIFIC CORPORATION: KEY DEVELOPMENTS 128

TABLE 105 INTUITIVE SURGICAL: PRODUCT OVERVIEW 130

TABLE 106 INTUITIVE SURGICAL: KEY DEVELOPMENTS 131

TABLE 107 C. R. BARD, INC.: PRODUCT OVERVIEW 133

TABLE 108 C. R. BARD, INC.: KEY DEVELOPMENTS 135

TABLE 109 DORNIER MEDTECH: PRODUCT OVERVIEW 137

TABLE 110 DORNIER MEDTECH: KEY DEVELOPMENTS 137

TABLE 111 KONINKLIJKE PHILIPS N.V.: PRODUCT OVERVIEW 139

TABLE 112 KONINKLIJKE PHILIPS N.V.: KEY DEVELOPMENTS 141

TABLE 113 B. BRAUN MELSUNGEN AG: PRODUCT OVERVIEW 144

TABLE 114 B. BRAUN MELSUNGEN AG: KEY DEVELOPMENT 146

TABLE 115 SANOFI: KEY DEVELOPMENTS 149



FIGURE 1 GLOBAL GALL BLADDER TREATMENT MARKET BY DISEASE INDICATION MARKET SHARE 2016 (%) 14

FIGURE 2 GLOBAL GALL BLADDER TREATMENT MARKET BY DIAGNOSIS MARKET SHARE 2016 (%) 15

FIGURE 3 GLOBAL GALL BLADDER TREATMENT MARKET BY TREATMENT MARKET SHARE 2016 (%) 16

FIGURE 4 GLOBAL GALL BLADDER TREATMENT MARKET BY END USERS MARKET SHARE 2016 (%) 17

FIGURE 5 GLOBAL GALL BLADDER TREATMENT MARKET BY REGION MARKET SHARE 2016 (%) 18

FIGURE 6 GLOBAL GALLBLADDER TREATMENT MARKET: MARKET STRUCTURE 20

FIGURE 7 RESEARCH PROCESS 21

FIGURE 8 FORECAST MODEL 24

FIGURE 9 PORTERS FIVE FORCES MODEL 29

FIGURE 10 GLOBAL GALL BLADDER TREATMENT MARKET BY DISEASE INDICATION US$ MILLION 2016 & 2023 38

FIGURE 11 GLOBAL GALL BLADDER TREATMENT MARKET BY DIAGNOSIS US$ MILLION 2016 & 2023 43

FIGURE 12 GLOBAL GALL BLADDER TREATMENT MARKET BY TREATMENT US$ MILLION 2016 & 2023 49

FIGURE 13 GLOBAL GALL BLADDER TREATMENT MARKET BY END USERS US$ MILLION 2016 & 2023 52

FIGURE 14 GLOBAL GALL BLADDER MARKET BY REGION US$ MILLION 2016 & 2023 54

FIGURE 15 NORTH AMERICA GALL BLADDER MARKET BY REGION US$ MILLION 2016 & 2023 55

FIGURE 16 EUROPE GALL BLADDER MARKET BY REGION US$ MILLION 2016 & 2023 65

FIGURE 17 ASIA PACIFIC GALL BLADDER MARKET BY REGION US$ MILLION 2016 & 2023 87

FIGURE 18 MIDDLE EAST & AFRICA GALL BLADDER MARKET BY REGION US$ MILLION 2016 & 2023 109

FIGURE 19 GLOBAL GALL BLADDER TREATMENT MARKET COMPETITIVE ANALYSIS 2016 (%) 125

FIGURE 20 BOSTON SCIENTIFIC CORPORATION: RECENT FINANCIAL: REVENUE $ MILLION 127

FIGURE 21 BOSTON SCIENTIFIC CORPORATION: GEOGRAPHIC SEGMENTATION 2016 (%) 127

FIGURE 22 BOSTON SCIENTIFIC CORPORATION: PRODUCT SEGMENTATION 2016 (%) 128

FIGURE 23 BOSTON SCIENTIFIC CORPORATION: SWOT 129

FIGURE 24 INTUITIVE SURGICAL: FINANCIAL OVERVIEW, 2016 (USD MILLION) 130

FIGURE 25 INTUITIVE SURGICAL: GEOGRAPHICAL SEGMENTATION, 2016 (%) 131

FIGURE 26 INTUITIVE SURGICAL: SWOT 132

FIGURE 27 C. R. BARD, INC.: FINANCIAL OVERVIEW, 2016 (USD MILLION) 134

FIGURE 28 C. R. BARD, INC.: GEOGRAPHICAL SEGMENTATION, 2016 (USD MILLION) 134

FIGURE 29 C. R. BARD, INC.: SWOT 136

FIGURE 30 DORNIER MEDTECH: SWOT 138

FIGURE 31 KONINKLIJKE PHILIPS N.V.: RECENT FINANCIAL 140

FIGURE 32 KONINKLIJKE PHILIPS N.V.: GEOGRAPHICAL MIX 140

FIGURE 33 KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS 141

FIGURE 34 KONINKLIJKE PHILIPS N.V.: SWOT ANALYSIS 143

FIGURE 35 B. BRAUN MELSUNGEN AG: RECENT FINANCIALS 145

FIGURE 36 B. BRAUN MELSUNGEN AG: DIVISION SALES (%) 145

FIGURE 37 B. BRAUN MELSUNGEN AG: GEOGRAPHICAL SEGMENTATION % 146

FIGURE 38 B. BRAUN MELSUNGEN AG: SWOT ANALYSIS 147

FIGURE 39 SANOFI: FINANCIAL OVERVIEW: REVENUE $ MILLION 149

FIGURE 40 SANOFI: SWOT 150